ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BHVN vs PBH // 10Y YIELD & FRED MACRO BETA

Biohaven Ltd. (NYSE) VS. Prestige Consumer Healthcare Inc. (NYSE) • 15-METRIC TALLY: BHVN 2 — PBH 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BHVN VS. PBH) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BHVN PBH SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 54.70% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 13.80% -48.80 PBH /roic <GO>
EV/EBITDA & P/E Valuation — 7.0x — TIE /valuation <GO>
Free Cash Flow Yield -24.50% 10.67% -35.17 PBH /fcf-yield <GO>
Operating Margin — 28.40% — TIE /operating-margins <GO>
Net Profit Margin — 17.50% — TIE /net-margins <GO>
Revenue Growth (YoY) — -4.30% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 2.21 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 6/9 -3.00 PBH /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 58.4 54.0 +4.40 BHVN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 11.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.33B $2.32B $5.1M BHVN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BHVN REV PBH REV BHVN GROSS % PBH GROSS % BHVN FCF PBH FCF
FY 2025 $2.09B $1.09B — 54.7% -$610.2M $246.4M
FY 2024 $2.48B $1.14B — 55.8% -$586.5M $243.3M
FY 2023 $1.22B $1.13B — — -$331.7M $248.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BHVN // BETA —
PBH // BETA —